KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Taxes (2016 - 2022)

Fulgent Genetics' Current Taxes history spans 6 years, with the latest figure at $426000.0 for Q3 2022.

  • For Q3 2022, Current Taxes fell 97.62% year-over-year to $426000.0; the TTM value through Sep 2022 reached $426000.0, down 97.62%, while the annual FY2021 figure was $787000.0, 98.52% down from the prior year.
  • Current Taxes for Q3 2022 was $426000.0 at Fulgent Genetics, down from $2.8 million in the prior quarter.
  • Across five years, Current Taxes topped out at $120.5 million in Q1 2021 and bottomed at $24000.0 in Q4 2019.
  • The 4-year median for Current Taxes is $8.7 million (2020), against an average of $24.1 million.
  • The largest annual shift saw Current Taxes soared 222062.5% in 2020 before it tumbled 98.52% in 2021.
  • A 4-year view of Current Taxes shows it stood at $24000.0 in 2019, then skyrocketed by 222062.5% to $53.3 million in 2020, then tumbled by 98.52% to $787000.0 in 2021, then crashed by 45.87% to $426000.0 in 2022.
  • Per Business Quant, the three most recent readings for FLGT's Current Taxes are $426000.0 (Q3 2022), $2.8 million (Q2 2022), and $52.2 million (Q1 2022).